Production of a Fibrinolytic Enzyme in Bioreactor Culture by Bacillus subtilis BK-17

  • Lee, Jin-Wook (Department of Chemical Engineering, Pusan National University) ;
  • Park, Sung-Yurb (Department of Chemical Engineering, Pusan National University) ;
  • Choi, Won-A (Department of Chemical Engineering, Pusan National University) ;
  • Lee, Kyung-Hee (Pharmaceutical Department, Pusan National University) ;
  • Jeong, Yong-Kee (Department of Microbiology, Dong-Eui University) ;
  • Kong, In-Soo (Department of Biotechnology and Bioengineering, Pukyong National University) ;
  • Park, Sung-Hoon (Department of Chemical Engineering, Pusan National University)
  • 발행 : 1999.08.01

초록

Bacillus subtilis BK-17 which produces a novel protease with fibrinolytic activity was isolated from soybean paste. Bioreactor production of the enzyme was studied in order to optimize fermentation conditions such as medium concentration, pH, agitation speed, and temperature. Under most cultural conditions, enzyme production initially began when the cell growth stopped. The onset of the enzyme production was indicated by rapid increase in both dissolved oxygen (DO) and pH. Two- to three-times more concentrated medium than the flask optimum medium yielded higher enzyme production in the bioreactor fermentation. When the medium pH was controlled constant, pH 6.5 exhibited the highest activity in the range of 6.0 to 7.5, but the activity was similar to the case when the pH was initially adjusted to 7.5 and subsequently maintained within a relatively wide range of 6.4 to 7.8. Agitation speed did not affect the enzyme production with an exception of DO reaching zero. Fermentation time was reduced when temperature increased within the range of $25^{\circ}C$ to$37^{\circ}C$. However, the highest activity, along with the slow decrease of the enzymatic activity after reaching the maximum value, was observed at $25^{\circ}C$. By shifting the temperature from $37^{\circ}C$ to $25^{\circ}C$immediately after DO reached the minimum level, the high enzyme production of 1,100 U/ml along with the short fermentation period of 13 h could be obtained.

키워드

참고문헌

  1. Blood and Vessels (in Japanese) v.13 Shift of fibrinolysis system at oral administration of urokinase in buman subjects: Double blind cross over study Abe, T.;M. Kazama;T. Kinoshita;I. Naito;T. Ogushi;Y. Yoshimura;J. Teruya;N. Shimizu
  2. Arch. Biochem. Biophys v.40 The fibrin plate method for estimating fibrinolytic Activity Astrup, T.;S. Mullertz
  3. Statistics of '96 death toll in Korea, Department of Population Analysis Anonymous
  4. Biochemical Engineering Fundamentals (2nd ed.) Bailey, J. E.;D. F. Ollis
  5. Korean. J. Biotechnol. Bioeng v.13 Effects of enviromental and nutritional conditions on fibrinolytic enzyme production from Bacillus subtilis BK-17 in flask culture Choi, W.-A.;J.-W. Lee;K-H. Lee;S.-H. Park
  6. Enzyme Microb. Technol v.14 Production and degradation of alkaline protease in batch cultures of Bacillus subtilis ATCC 14416 Chu, I.-M.;C. Lee;T.-S. Li
  7. Progress in Cardiovascular Diseases v.34 Towards better thrombolytic therapy Collen, D.;H. R. Kijnen;H. K. Gold
  8. J. Gen. Microbiol v.81 Studies on the formation of bacitracin by Bacillus licheniformis: Role of catabolite repression and organic acids Haavik, H. I.
  9. J. Gen. Microbiol v.84 Studies on the formation of bacitracin by Bacellus licheniformis: Role of catabolite repression and organic acids Haavik, H. I.
  10. J. Gen. Microbiol v.128 The influence of glucose, ammonium and magnesium availability on the production of protease and bacitracin by Bacillus licheniformis Hanlon, G. W.;N. A. Hodges;A. D. Russell
  11. Appl. Microbiol. Biotechnol v.40 Production of alkaline serine protease subtlisin Carlsberg by Bacillus licheniformis on complex medium in a stirred tank reactor Hubner, U.;U. Bock;K. Schugerl
  12. Fibrinolutic enzyme isolated from Bacillus subtilis Jung, Y.-K.;I.-S. Kong;S.-H. Park
  13. J. Ferm. Bioeng v.84 Purification and characterization of a novel fibrinolytic enzyme from Bacillus sp. KA38 originated from fermented fish Kim, H.-K.;G.-T. Kim;D.-K. Kim;W.-A. Choi;S.-H. Park;Y.-K. Jeong;I-S. Kong
  14. Appl. Environ. Microbiol v.62 Purification and characterization of a fibrinolytic enzyme produced from Bacillus sp. straon CK-14 screened from Chungkook-Jang Kim, W.;K. Choi;Y. Kim;H. Park;J. Choi;Y. Lee;H. Oh;I. Kwon;S. Lee
  15. J. Bacteriol v.93 Regulation of extracellular protease production in Bacillus cereus Levisohn, S.;A. I. Aronson
  16. Lumbricus rubellus. Jpn. J. Physiol v.41 A novel fibrinolytic enzyme extracted from the earthworm Mihara, H.;H. Sumi;T. Yoneta;H. Mizumoto;R. Ikeda;M. Seiki;M. Maruyama
  17. Anal. Chem v.31 Use of dinitrosalicylic acid reagent for determination of reducing sugar Miller, G. L.
  18. Biosci. Biotech. Biochem v.56 Nucleotide sequence of the subtilisin NAT gene, aprN, of Bacillus subtilis (natto) Nakamura, T.;Y. Yamagata;E. Ichishima
  19. Bacteriol. Rev v.41 Extracellular enzyme synthesis in the genus Bacillus Priest, F. G.
  20. Folia Microbiol v.32 Formation of extracellular neutral proteinase and the stringent response in Bacillus subtilis Riedel, K.;A. Schroeter;P. Liebs;J-P. GrabaM. Hecker;D. Schrapel
  21. Blood v.66 The transport of $^125I$-labeled human high molecular weight urokinase across the intestinal tract in a dog model with stimulation of synthesis and/or release of plasminogen activators Sasaki, K.;S. Moriyama;H. Sumi;N. Toki;K. C. Robbins
  22. Bacteriol. Rev v.33 Sporulation and the production of antibiotics, exoenzymes, and exotoxins Schaeffer, P.
  23. Experientia v.43 A novel fibrinolytic enzyme (Nattokinase) in the vegetable cheese natto: A Typical and popular soybean food in the Japanese diet Sumi, H.;H. Hamada;H. Tsushima;H. Mibara;H. Muraki
  24. Acta Haematol v.70 Activation of plasma fibrinolysis after intrarectal administration of high molecular weight urokinase and its dericative Sumi, H.;M. Maruyama;T. Yoneta;H. Mihara
  25. Enzyme v.33 Plasma fibrinolysis after intraduodenal adminostration of urokinase in rats Sumi, H.;M. Seiki;N. Morimoto;H. Tsushima;M. Maruyama;H. Mihara
  26. Thromb. Res v.20 Oral administration of urokinase Sumi, H.;N. Toki;K. Sasaki;K. C. Robbins
  27. J. Clin. Invest v.75 Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins Toki, N.;H. Sumi;K. Sasaki;I. Boreisha;K. C. Robbins
  28. Drugs v.50 Thrombolytic agents in development Verstraete, M.;H. R. Lijnen;D. Collen
  29. Comprehensive Biotechnology v.3 Proteolytic enzymes Ward, O. P.;M. Moo-Young(ed.)